Skip to main content

Advertisement

Table 1 Characteristics of study population at baseline

From: Inflammation-associated microRNA changes in circulating exosomes of heart failure patients

  Cases Controls Overall p value
Number 40 20 60  
Age—year (SD) 66.5 (10.5) 60.6 (15.7) 64.5 (12.6) 0.09
Sex—no. (%)     0.16
 Male 40/40 (100%) 19/20 (95%) 59/60 (98%)  
Race—no. (%)
 White 31/40 (78%) 16/20 (80%) 47/60 (80%) 0.82
 African American 9/40 (22%) 3/20 (15%) 3/20 (15%) 0.50
 Others   1/20 (5%) 1/20 (5%) 0.16
Body mass index (SD) 30.4 (7.4) 28.8 (6.1) 29.9 (7.0) 0.40
Medical history—no. (%)
 Hypertension 32/40 (80%) 11/20 (55%) 43/60 (72%) 0.04
 Type 2 diabetes 23/40 (58%) 3/20 (15%) 26/60 (43%) 0.01
 Coronary artery disease 23/40 (58%) 2/20 (10%) 25/60 (42%) 0.00
 Chronic kidney disease 21/40 (53%) 1/20 (5%) 22/60 (37%) 0.00
 Alcohol abuse 3/40 (8%) 1/20 (5%) 4/60 (7%) 0.72
 Drug use 3/40 (8%) 2/20 (10%) 5/60 (8%) 0.74
Medications—no. (%)
 Aspirin 34/40 (85%) 6/20 (30%) 40/60 (67%) 0.00
 Beta-blocker 38/40 (95%) 7/20 (35%) 45/60 (75%) 0.00
 ACE/ARB 35/40 (88%) 2/20 (10%) 37/60 (62%) 0.00
 Spirinolactone 16/40 (40%) 0/20 (0%) 16/60 (27%) 0.00
 Statin 34/40 (85%) 9/20 (45%) 43/60 (72%) 0.00